80085-68-3

Downstream Products

• 80087-22-5 1-methyl-5-(3-benzoylpropyl)thio-1,2,3,4-tetrazole 
• 136622-13-4 N-<3-<3-<(3-Hydroxy)pyrrolidinomethyl>phenoxy>propyl>-4-(1-methyl-1H-tetrazol-5-ylthio)butanamide 
• 136622-12-3 N-<3-<3-(Pyrrolidinomethyl)phenoxy>propyl>-4-(1-methyl-1H-tetrazol-5-ylthio)butanamide 
• 136622-15-6 N-[3-(3-{[(2-Hydroxy-ethyl)-methyl-amino]-methyl}-phenoxy)-propyl]-4-(1-methyl-1H-tetrazol-5-ylsulfanyl)-butyramide 
• 136622-14-5 N-[3-(3-Dimethylaminomethyl-phenoxy)-propyl]-4-(1-methyl-1H-tetrazol-5-ylsulfanyl)-butyramide 
• 136621-88-0 N-<3-<(3-Chloromethyl)phenoxy>propyl>-4-(1-methyl-1H-tetrazol-5-ylthio)butanamide 

Relevant academic research and scientific papers

TETRAZOLE DERIVATIVES, AND ANTI-ULCER COMPOSITION CONTAINING THE SAME

Tetrazole derivatives of the formula: STR1 wherein R 1 is a lower alkykl, phenyl or a group of the formula:--S(O) l--A--(X) m--R 3, and R 2 is hydrogen, a lower alkyl, phenyl or a cycloalkyl when R 1 is the group--S(O) l--A--(X) m--R 3, or R 2 is a group of the formula:--B--CO--R 4 when R 1 is a lower alkyl or phenyl and a pharmaceutically acceptable salt thereof, which have prophylactic or therapeutic activities against peptic and/or duodenal ulcers and are useful as an anti-ulcer drug; processes for the preparation of the tetrazole derivatives; and pharmaceutical composition containing said tetrazole derivatives.